← Oncology Approval Tracker

FDA DECISION ·

Imdelltra

tarlatamab-dlle · Amgen

Traditional approvalTraditional conversionSmall cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with extensive-stage small cell lung cancer that progressed on or after platinum-based chemotherapy.

LAMPGEN ANALYSIS

Why it matters

Randomized survival evidence converted the earlier accelerated approval of this DLL3-targeted bispecific antibody.

What research teams should watch

Review step-up dosing capacity and set clear inpatient and outpatient handoffs for cytokine release syndrome and neurotoxicity monitoring.

PRIMARY RECORDS

Sources